Stay updated on Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a 'Locations' section that includes Texas as a study site. The older 'Texas Locations' label was removed and the HHS Vulnerability Disclosure link was deleted in this revision.
    Difference
    0.2%
    Check dated 2025-12-21T21:12:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-30T03:46:13.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Publications section updated from 'No Results Posted' to 'Results Submitted', with an explanatory note that PubMed-listed publications are automatically filled from PubMed and may not be about the study.
    Difference
    0.2%
    Check dated 2025-11-23T08:17:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page. This is an administrative update that does not pertain to the study details.
    Difference
    0.4%
    Check dated 2025-11-16T06:50:31.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Publications section updated with the 2025 Blood Advances article detailing the phase 2 trial of ibrutinib and nivolumab in relapsed CNS lymphoma. The study record shows a last update posted on 2025-02-28.
    Difference
    0.4%
    Check dated 2025-11-02T00:35:35.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Major update to the page content: a government-operating status notice and a new version tag (v3.2.0) replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-04T12:31:37.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.